Grace Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
Grace Therapeutics, Inc. (GRCE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 1.33 million shares for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-23.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2023-06-23
- Grace Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2023 was 1.33M shares, a 260.10% increase from fiscal 2022.
- Grace Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2022 was 369.67K shares, a 78.51% decline from fiscal 2021.
- Grace Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2021 was 1.72M shares, a 4.33% decline from fiscal 2020.
- Grace Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2020 was 1.80M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 12 month |
|---|---|
| 2023-03-31 | 1.33M shares 10-K · filed 2023-06-23 |
| 2022-03-31 | 369.67K shares 10-K · filed 2022-06-21 |
| 2021-03-31 | 1.72M shares 10-K · filed 2021-06-22 |
| 2020-03-31 | 1.80M shares 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |